Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0001415889-25-002292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-29 | 2025-01-27+ | TLSI | Szela Mary T | CEO AND Pres, Dir | P - Purchase | $5.27 | +9,542 | 429.5K | +2% | +$50.3K |
| D | 2025-01-29 | 2025-01-27 | TLSI | Szela Mary T | CEO AND Pres, Dir | A - Grant | $0.00 | +40.0K | 424.7K | +10% | $0 |
| D | 2025-01-29 | 2025-01-27 | TLSI | Szela Mary T | CEO AND Pres, Dir | A - Grant | $0.00 | +240.0K | 240.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | P | A | 4,716 | $5.12 | 434,219 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 2 | Common | Common Stock | 2025-01-27 | P | A | 4,826 | $5.42 | 429,503 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.25 to $5.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2025-01-27 | A | A | 40,000 | $0.00 | 424,677 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-01-27 | A | A | 240,000 | $0.00 | 240,000 | D | $5.30 · — to 2035-01-26 | 240,000 Common Stock | (F4) One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. |